Arecor Therapeutics (LON:AREC) Sets New 12-Month Low at $130.00

Arecor Therapeutics plc (LON:ARECGet Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 130 ($1.62) and last traded at GBX 130.24 ($1.62), with a volume of 16323 shares changing hands. The stock had previously closed at GBX 132.50 ($1.65).

Arecor Therapeutics Price Performance

The business has a 50-day moving average price of GBX 142.73 and a 200 day moving average price of GBX 168.33. The company has a current ratio of 2.52, a quick ratio of 6.24 and a debt-to-equity ratio of 1.26. The company has a market cap of £39.36 million, a price-to-earnings ratio of -414.52 and a beta of -0.22.

Arecor Therapeutics Company Profile

(Get Free Report)

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Featured Stories

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with's FREE daily email newsletter.